The Jenner Institute, along with MilliporeSigma, is preparing for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. Patients are currently enrolled in clinical trials for the vaccine, which will require rapid development of the large-scale manufacturing process quickly and safely. Leveraging MilliporeSigma’s previous work allowed for plans to scale-up the manufacture of Jenner’s Covid-19 vaccine candidate. Developing the manufacturing process itself would ...